Crossmark

Immune-related adverse events in cancer patients referred to the palliative care team of a tertiary care center: a retrospective observational study

Published Online: 2024-11-15

Published Print: 2024-12

Authors

Yanaizumi, Ryota

Nagamine, Yusuke

Harada, Shinsuke

Goto, Takahisa
License Information

Text and Data Mining valid from 2024-11-15

Version of Record valid from 2024-11-15
More Information

Article History

Received: 13 June 2024

Accepted: 11 November 2024

First Online: 15 November 2024

Declarations

: All procedures involving human participants performed in this study were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of Yokohama City University Medical Center (F220500067; August 4, 2022), Yokohama, Japan. The requirement for written informed consent was waived by the Ethics Committee.

: The requirement for written informed consent was waived due to the retrospective nature of this study.

: All authors consent to publication of this article in Supportive Care in Cancer.

: The authors declare no competing interests.

Document is current